non recurring

Related by string. nonrecurring * Non . NON . nOn . nons . - - Non : non farm payrolls . Non GAAP net . Non Aligned Movement NAM . Non GAAP Measures . Non Brokered Private Placement . Non GAAP Financial / Recurring . recurred . RECURRING : recurring theme . recurring themes . recurring nightmares . Recurring FFO . Non recurring * Non Recurring Items . NON RECURRING ITEMS . Excluding Non Recurring *

Related by context. All words. (Click for frequent words.) 78 nonrecurring 72 amortization expense 72 nonrecurring items 70 asset impairment 69 Non recurring 69 Adjusted EBITDA excludes 68 pension curtailment 68 goodwill impairment 68 intangible impairment 67 asset impairments 66 amortization 66 impairment charges 66 compensation expense 66 goodwill impairment charge 66 discontinued operations 66 unallocated expenses 65 depreciation amortization 65 debt extinguishments 65 unallocated corporate 64 intangible asset impairments 64 nonrecurring expenses 64 asset impairments restructuring 64 impairment charge 64 LIFO adjustment 64 items affecting comparability 64 intangibles amortization 63 LIFO inventory valuation 63 DAC unlock 63 pretax 63 diluted share 63 f Represents 63 d Represents 63 diluted EPS 63 excluding nonrecurring 63 Equinix excludes 62 intangibles impairment 62 debt extinguishment 62 OSIs 62 goodwill amortization 62 affecting comparability 62 LIFO adjustments 62 Excluding 62 b Represents 61 unrealized hedging 61 temporary impairments OTTI 61 infrequently occurring 61 excluding 61 f Reflects 61 early extinguishment 61 noncash impairments 61 operatingincome 61 Adjusted EBITDA 61 currency translation 61 inventories revalued 61 LIFO accounting 60 c Excludes 60 nonroutine income 60 early extinguishments 60 Adjusted 60 goodwill impairments 60 currency remeasurement 60 hedge ineffectiveness 60 Pro forma adjustments 60 intangible asset 60 adopting SFAS #R 60 noncash goodwill impairment 60 Surface Specialties acquisition 60 unrealized derivative 59 b Reflects 59 intangible assets impairment 59 Non GAAP adjusted EBITDA 59 OTTI charges 59 intangible amortization 59 adjusted EBITDA 59 Adjusted diluted 59 Pro forma net 59 Pro forma EPS 59 excluding goodwill impairment 59 Nonrecurring 59 unfavorable variance 59 b Excludes 59 netincome 59 noncash accounting 59 unrealized derivative gains 59 pretax goodwill impairment 59 uncollectible accounts receivable 59 intangible assets 59 pro forma 58 unrealized gains 58 Excluding goodwill impairment 58 accrual reversal 58 EBITDA 58 FAS CAS pension 58 EUR -#.# -#.# [001] 58 asset valuation allowance 58 Consolidated Adjusted EBITDA 58 Unusual Items section 58 non GAAP 58 Normalised earnings 58 EUR -#.# [001] 58 DAC unlocking 58 Adjusted EPS 58 stock basedcompensation 58 accruals 58 ended September# 58 impacting comparability 58 noninterest expense decreased 58 profitsharing 58 #.# perdiluted 57 Visa indemnification 57 SEK -#.# -#.# [003] 57 g Represents 57 Pretax 57 amortizable intangible assets 57 aftertax 57 Excluding discontinued operations 57 severance accruals 57 GSCT program 57 Qualcomm Strategic Initiatives 57 preopening expenses 57 GAAP 57 noncash 57 Unusual Items 57 SEK -# 57 MA PFFS 57 c Represents 57 Timeshare segment 57 EBIT 57 incentive accruals 57 valuation allowance 57 lease terminations 57 Consolidated EBITDAR 57 intercompany balances 57 pro forma adjusted EBITDA 56 per dilutedshare 56 Non GAAP net 56 noninterest expense 56 c Reflects 56 FDIC indemnification 56 Significant Items 56 intangible impairments 56 Core FFO 56 nonoperating expenses 56 #.#-#.# excluding 56 adjusted EBITDAR 56 IAROC 56 excludes unrealized gains 56 nonoperating items 56 Adjusted OIBDA excludes 56 LIFO expense 56 EBIT amounted 56 Pro forma 56 noninterest expenses 56 OTTI charge 56 ATCF 56 NOL utilization 56 Unizan merger 56 Non GAAP 56 administrative expenses 56 depletion depreciation 56 nonoperating expense 56 FAS #R 56 DiaMed acquisition 56 fiscal# 56 Adjusted Earnings 56 excludes depreciation amortization 56 valuation adjustments 56 unamortized deferred 56 Pro forma Adjusted EBITDA 56 earnings pershare 56 operating income1 56 foreign currency remeasurement 56 #.#per diluted 56 noncash goodwill 56 inventory write downs 56 Pro forma EBITDA 55 OREO write downs 55 shutdowns asset impairments 55 j Includes 55 LIFO inventory 55 MSEK -# [002] 55 postretirement benefit 55 Normalized EPS 55 exclude noncash 55 accretion expense 55 n#.# [002] 55 Partially offset 55 noncash impairment charge 55 prioryear 55 Net income 55 LIFO liquidation 55 dis synergies 55 acquired intangibles 55 expensed 55 non gaap 55 QUALCOMM Strategic Initiatives 55 Exceptional Items 55 Pro Forma EBITDA 55 EBITA 55 c Consists 55 Items impacting comparability 55 DKK #m 55 loss NOL carryforward 55 EBITDAO 55 SFAS #R 55 Negatively impacting 55 Consolidated OIBDA 55 Segment EBIT 55 AGY Asia 55 Non GAAP adjustments 55 aftertax gain 55 reinstatement premiums 55 Currency translation 55 CASM excluding fuel 55 accrual reversals 55 c Relates 55 b Includes 55 Adjusted EBIT 55 MDP Transaction 55 PTOI 55 Including discontinued operations 55 Restructuring 55 nonoperating income 55 acquired intangible assets 54 accretion DD & 54 unamortized financing 54 -Celine Dion Eric Clapton 54 unabsorbed overhead 54 Items excluded 54 valuation allowances 54 identifiable intangible assets 54 d Reflects 54 MSEK -# [001] 54 excluding depreciation amortization 54 noncash impairment 54 noncash amortization 54 equity investee 54 accelerated depreciation 54 depreciation amortization impairment 54 GAAP EPS 54 NON RECURRING ITEMS 54 NETg acquisition 54 #.#/diluted share 54 EBITDAS 54 non capitalizable 54 unamortized debt 54 taxes depreciation amortization 54 quarter# 54 Adjusted Diluted EPS 54 depreciable assets 54 Unallocated corporate 54 compensation accruals 54 deductible goodwill impairment 54 Asset impairment 54 Individual Annuities segment 54 Normalized EBITDA 54 depreciation amortization depletion 54 FAS #R expense 54 Estimates typically exclude 54 temporary impairment OTTI 54 Impairment Charge 54 - Adjusted [025] 54 nonoperating 54 unconsolidated investee 54 Stendal mill 54 adjusted EBITDAS 54 Operating expenses 54 OREO valuation 54 EUR#.#million 54 remeasurement 54 BIBP 54 intersegment revenues 54 SEK -#.# [002] 54 favorably impacted 54 millioncompared 54 continuingoperations 54 intercompany loans 54 aftertax charge 54 MSR valuation 54 TEB adjustment 54 normalized EBIT 53 pretax noncash 53 distort comparability 53 unamortized portion 53 noncash pretax 53 unamortized deferred financing 53 depreciation amortization accretion 53 SG & 53 b Relates 53 Diluted EPS attributable 53 intercompany eliminations 53 unbilled revenue 53 MNOK #.# 53 adjusted EPS 53 invoiced shipments 53 intersegment eliminations 53 items impacting comparability 53 GBP #.#m [003] 53 Positively impacting 53 Wireline segment 53 FAS CAS Pension 53 Derivative Liabilities 53 Pharmacia Monsanto 53 Pro Forma EPS 53 remeasurements 53 -Gottron 53 Fully diluted earnings 53 gross margin 53 pro forma basis 53 Projected FFO 53 accrual 53 ofapproximately 53 temporary impairments 53 adjusted distributable cash 53 goodwill intangible 53 Adjusted EBTIDA 53 INOVA Geophysical 53 Items affecting comparability 53 Diluted EPS 53 normalized EBITDA 52 Ps.#.# [007] 52 Earnings Excluding Specified 52 Excluding nonrecurring items 52 #.#/BOE [002] 52 unabsorbed fixed manufacturing 52 c Includes 52 LIFO reserve 52 EURO#.# [002] 52 PMPS brand 52 Debt Extinguishment 52 Drivetrain segment 52 Net Income 52 Impairment Charges 52 Adjusted FFO 52 unrealized losses 52 - AdjusETON 52 reinsurance commutations 52 nonGAAP 52 primarily attributable 52 deferred loan origination 52 -Senanu 52 depreciation depletion amortization 52 pro forma EBITDA 52 - Adjusted [028] 52 intersegment transactions 52 OPEB expense 52 CASM excluding 52 excludes noncash 52 asset impairments severance 52 MSR hedging 52 Interest expense decreased 52 adjusted2 52 Unallocated expenses 52 unfavorably impacted 52 Fine Chemicals segment 52 Non Recurring 52 Partnered Brands segment 52 Reconciling Items 52 EDITDA 52 Asset Impairment 52 AMPAC ISP Holdings 52 Intangibles amortization 52 depreciation 52 LPT Agreement 52 unamortized 52 Ps.3 52 noncash intangible 52 - Adjusted [010] 52 EBITDA1 52 FFO 52 MSR impairment 52 currency translations 52 adjusted EBIT 52 Octane Additives 52 capital expenditures 52 Futureway Communications Inc. 52 Amortiz 52 unrealized derivative gain 52 Visa MasterCard antitrust 52 exceptionals 52 DKK #.#bn [001] 52 excluding BIBP 52 Q#/# EUR [002] 52 Non GAAP Adjusted EBITDA 52 thefourth quarter 52 taxes EBDDT 52 carryforwards 52 Adjusted EBT 52 Specified Items 52 deconsolidation 52 amortization EBITDA 52 forecasts typically exclude 52 Pro forma adjusted EBITDA 51 goodwill writedown 51 Goodwill impairment charge 51 EnPro consolidated 51 Nonrecurring items 51 Chemicals Segment 51 Debt extinguishment costs 51 No. #R 51 - Adjusted [030] 51 excluding depreciation depletion 51 Excludes amortization 51 Asset Impairment Charge 51 Consolidated EBITDA 51 DPAC amortization 51 BlackRock MLIM transaction 51 accretable 51 No. #R SFAS 51 SEK -#.# [001] 51 Unlevered Cash Flow 51 EBITDAF 51 - Non GAAP [009] 51 OIBA 51 noncash pretax charge 51 purchased intangible assets 51 Operational EBITDA 51 SFAS# R 51 Extra Ordinary Items 51 MEUR -#.# 51 identifiable intangibles 51 Restructuring impairment 51 Valuation allowance 51 TWACS NG software 51 Unallocated Corporate 51 FSP #-# 51 credit carryforwards 51 depreciation noncash 51 Arana Therapeutics Limited 51 depreciation accretion 51 Discontinued Operations 51 Hesperion acquisition 51 modestly dilutive 51 YTD Fiscal 51 owned OREO 51 noninterest income 51 Copano commodity 51 Adjusted OIBDA 51 Xantic acquisition 51 fuel CASM 51 CAD#m [002] 51 Q2 FY'# 51 inventory obsolescence 51 Diluted earnings 51 Non GAAP EPS 51 Operating Income 51 EBDDT 51 EUR# mn [001] 51 Net Loss 51 Background Screening segment 51 adjusted OIBDA margin 51 FFOM 51 Harland Acquisition 51 mainline CASM excluding 51 DJO Merger 51 warranty accruals 51 unevaluated properties 51 Normalised 51 NOL carryforwards 51 - - Earnunderwent resection 51 EUR #,# Mio 51 SEK -#.# [003] 51 EBITDAA 51 - Adjusted [013] 51 ELIOKEM 51 Mainline CASM excluding 51 equity accounted investees 51 postretirement benefits 51 Amorti 51 Free Cash Flow 51 Equity Investees 51 - Adjusted [012] 51 unrealized gain 51 client reimbursables 51 unamortized issuance costs 51 Order Backlog 51 DAC offsets 51 principally attributable 51 EUR -#.# [003] 51 Filtran Microcircuits Inc. 51 excluding divestments 51 OTTI 51 retrospectively adjusted 51 acquisitions divestitures transfers 51 identifiable intangible 51 IBNR reserves 51 unrealized depreciation 51 Q1 FY'# 51 - Adjusted [016] 51 - Adjusted [006] 51 Asset impairments 51 strategic alliances divestitures 51 Banks.com s 51 FASB Statement #R 51 Compensation Expense 51 Non GAAP diluted 51 3Q FY# 51 SEK -#.# -#.# [002] 51 amortization EBIDTA 51 postretirement expense 51 - Adjusted [034] 50 -Josephine Marcotty 50 per MCFE 50 Tecstar Automotive Group 50 NMHG Retail 50 Oxy ER 50 excluding exceptionals 50 invoiced shipment 50 Assumed provision 50 pershare 50 Continuing Operations 50 ascompared 50 Noninterest expenses 50 Innovis Entities 50 Pigments segment 50 LIFO inventory adjustments 50 divestiture 50 - Adjusted [024] 50 NONRECURRING ITEMS 1 50 Operating Expenses 50 Incurred 50 EURO#.# [001] 50 Comparable EBITDA 50 Compensation Expenses 50 Accelerated depreciation 50 Depreciation Amortization 50 intercompany 50 LIFO 50 Q2 FY# [001] 50 - - Net [047] 50 reasonably estimable 50 excludes depreciation 50 unabsorbed manufacturing 50 purchased intangibles 50 revenues excluding nonrecurring 50 unrealized appreciation 50 PGP Acquisition 50 NOK#.# [006] 50 Restructuring Charges 50 fully diluted 50 Current Installments 50 Non IFRS 50 capitalizable 50 Adjusted EBITDAX 50 extinguishment 50 Pro forma diluted 50 Other Income Expense 50 Business.com Acquisition 50 DNOI 50 IPRD 50 REBIT 50 excludes amortization 50 FASB #R 50 FSP APB #-# 50 nine monthsended 50 reimbursable expenses 50 consolidated OIBDA 50 income1 50 amortization DD 50 expenses totaled Ps 50 FFO FFO 50 unfavorable variances 50 divestitures 50 amortizable 50 -lipid nanoparticles 50 Capital expenditures 50 Noncash 50 Modified EBITDA 50 securitized Timeshare notes 50 Realized gains 50 Rs.#.# crores [006] 50 translation adjustment 50 partially offset 50 Concur excludes 50 Promotions.com subsidiary 50 NON CASH EXPENSES 50 - Adjusted [009] 50 Underlying EBIT 50 Goodwill impairment 50 excludes 50 Cobalt Gordian 50 accompanying condensed consolidated 50 adopting FAS #R 50 GBP #.#m [002] 50 LAE reserves 50 4Q FY# 50 nondeductible expenses 50 condensed consolidated statements 50 Adjusted FIFO EBITDA 50 accounts receivable balances 50 Filtran 50 -# TEUR 50 MFB Corp 49 anniversaried 49 - Adjusted [022] 49 EBDT 49 USD#.#m USD#.# per [002] 49 reportable segment 49 WWS Divestiture 49 Onshore Downstream 49 Q#/# EUR [001] 49 QSI SG & 49 Impairment Losses 49 MDS Proteomics 49 reinsurance recoveries 49 OIBDA 49 Add subtract 49 unconsolidated joint 49 Segment EBITDA 49 Before Unusual Items 49 Non GAAP Diluted EPS 49 Fabricated Products segment 49 Amortization 49 excluding nonrecurring items 49 amortisations 49 ONEOK Partners segment 49 months endedSeptember 49 Gross Addition CPGA 49 - - [019] 49 OTTI write downs 49 SFSB transaction 49 Order Bookings 49 Gross margin 49 EBIAT 49 standardized distributable cash 49 Rs.#.#cr 49 Based Compensation Expense 49 postretirement benefit plans 49 Adjusted Gross Profit 49 AFFO 49 noninterest expense totaled 49 asset disposals 49 quarterended 49 Interest Expense Interest expense 49 NOI decreased 49 EBITDAS EBITDA 49 Remainco 49 - Loss [013] 49 - INVESTING ACTIVITIES [004] 49 Adjusted Ebitda 49 OCF margin 49 Dropdown Predecessor 49 #M/# 49 derivative liabilities 49 financialstatements 49 Restructuring Charge 49 MtM gains 49 pretax noncash charges 49 Vinyls segment 49 normalized FFO 49 FAS# R 49 - Non GAAP [018] 49 reimbursables 49 Thomas Regout operations 49 Domilens 49 Than Temporary Impairments 49 UNUSUAL ITEMS 49 tables summarize 49 defeased loans 49 Interest expense 49 EBITD 49 bonus accruals 49 JPY#.# billion [001] 49 Discontinued operations 49 SFAS No. 49 depreciable real estate 49 EBITA amounted 49 LIFO inventory adjustment 49 depletion calculation 49 - Non GAAP [002] 49 -triseries 49 RCOP 49 Valhi stockholders 49 Olefins Polyolefins 49 andoperating 49 loss carrybacks 49 efficiency ratio teb 49 Recurring EBITDA 49 condensed consolidated 49 Discontinued Operation 49 LIFO inventory decrement 49 Stablex 49 Lodging Reported EBITDA 49 GBP #.#m [001] 49 leaseback transactions 49 unrealized gains losses 49 -Brad Dorfman editing 49 - -DARDEN 49 Futureway 49 marketable securities 49 deconsolidating 49 Noninterest expense decreased 49 proforma 49 QSI segment 49 ebita 49 Unrealized gains 49 Depreciations 49 Noninterest expense 49 dry dockings 49 Noninterest 49 Operating Expenses Operating 49 - -Corporatism 49 undernoted items 49 Prepaid churn 49 Catastrophe losses 49 - Income [004] 49 adjusted OIBDA 49 reserve reestimates 49 thirdquarter 49 proforma basis 49 Mainline CASM 49 LIFO inventory reserve 49 - Income [002] 49 Pro Forma Adjusted EBITDA 49 - Adjusted [020] 49 Polymer Additives segment 49 amortization OIBDA 49 Comparable FFO 49 Expenses 48 Noninterest expense totaled 48 FDIC indemnification asset 48 Excluding nonrecurring 48 ninemonths 48 discount accretion 48 Interest expense net 48 HealthStream Learning 48 Goodwill Impairment 48 Corus Aluminum 48 PGS Onshore acquisition 48 Iceland Latvia Lithuania 48 SEK -#.# -#.# [001] 48 acquisitions divestments 48 Variable Interest Entities VIEs 48 Yiyang Yukang 48 Mayne Pharma intangible assets 48 proforma EPS 48 unrealized derivative losses 48 PGiSend 48 intersegment sales 48 MSEK -#.# 48 - Adjusted EBITDA [001] 48 nondeductible portion 48 Hedge ineffectiveness 48 EBITDAC 48 Restructuring asset impairments 48 netsales 48 Recurring FFO 48 - Adjusted [026] 48 Partially offsetting 48 Scantron segments 48 accompanying unaudited consolidated 48 expenses LOE 48 Carrier ARW 48 Tadiran Communications Ltd. 48 restructuring 48 unconsolidated subsidiaries 48 acquisitions divestitures 48 thethird quarter 48 Xantic 48 LIFO provision 48 - Non GAAP [015] 48 AOCF 48 noninterest expense partially offset 48 Earnings 48 contingently issuable shares 48 Veraz excludes 48 Panamax Bulk Carrier 48 loan chargeoffs 48 - Loss [010] 48 #.# mln aud 48 postretirement benefit expense 48 investees partially offset 48 Reported Unaudited Condensed 48 Second Quarter Highlights 48 Adjustments Restructuring 48 EUR# mn [002] 48 - Loss [033] 48 addback 48 noncash unrealized 48 Additions Accrual Basis 48 Q1 #F 48 Merger Related 48 Cleco Midstream 48 WESTWOOD ONE INC. SUPPLEMENTAL 48 FIFO inventory 48 Adjusted Operating Margin 48 unitholder distributions 48 EBT amounted 48 All lease pmts 48 Excludes goodwill 48 doubtful accounts receivable 48 Adjusted Pro Forma 48 - Operating [026] 48 Adjusted EBITA 48 Adjusted pro forma 48 JasmineSola brand 48 DEPS 48 Segment Profit 48 ANOI 48 Supply Chain Transformation 48 Excluding acquisitions divestitures 48 SFAS 48 Unfavourable Changes 48 contingently convertible securities 48 timberland disposals net 48 - - [054] 48 - - Non GAAP [008] 48 Adjusted EBITDA1 48 earnout payments 48 Income Loss 48 PRE TAX OPERATING EARNINGS 48 millionfor 48 -#.# Mio 48 Items Affecting Comparability 48 - Adjusted [033] 48 - Loss [017] 48 antidilutive 48 -Angelo Nieves 48 tax npat 48 unamortised 48 loss carryforwards 48 Noninterest Expense Noninterest expense 48 FAS #R Share 48 Distributable 48 asset dispositions 48 MtM impacts 48 MEP Joint Venture 48 AIFRS 48 #compared 48 Fully diluted EPS 48 Ps.7 48 prepackaged medications 48 - IncomeMarkit Economics showed 48 Huarun minority interest 48 adopted SFAS #R 48 FASB Interpretation No. 48 noncash charge 48 FSAH Acquisition 48 noncash writedown 48 - Adjusted [017] 48 OnVista Group 48 Earnout 48 Synthetic Fuel segment 48 refundings 48 - - [015] 48 Adjusted EBITDAS 48 Statement #R 48 MIBRAG 48 Industrial CFOA 48 depreciation depletion 48 distributable earnings 48 undepreciated assets 48 From Operations AFFO 48 retroactive reinstatement 48 Mondi Hadera Paper 47 - Non GAAP [019] 47 FSP FAS #-# 47 - Ifreshly dug 47 hedging derivative instruments 47 SEK#M 47 - -OfficeMax ImPress R 47 Amortization EBITDA 47 Adjusted Operating 47 Byproduct revenues 47 quarter offiscal 47 - Loss [032] 47 c Calculated 47 ended December# 47 Adjusted OIBDAN 47 #.#/BOE [001] 47 proportionately consolidated 47 Exterran stockholders 47 Unitholder distributions 47 Reorganization Items 47 USD#.#m USD#.# [001] 47 recourse indebtedness 47 adjusted EBITA 47 undepreciated 47 incurs amortization 47 Nonutility 47 CAD#.# [001] 47 -cleveland.com 47 Lasertel subsidiary 47 £ #.#ma [005] 47 severance outplacement 47 Rs.#cr [001] 47 quarterof 47 Operating Cash Flow 47 Unilin segment 47 Offerors Commercial applies 47 - - Net [055] 47 divestures 47 SEK#.#m [003] 47 - Adjusted [027] 47 Eur #,# 47 mainline CASM 47 incurred 47 adjusted Ebitda 47 SILO LILO charges 47 Unrealized derivative 47 SG &A; 47 Consolidated adjusted EBITDA 47 AVONEX multiple sclerosis 47 - Adjusted [001] 47 LBITDA 47 intersegment 47 adopting SFAS 47 excl. 47 derivative instruments 47 adjusted EDITDA 47 YTD# 47 USD#.#m [007] 47 Scantron segment decreased 47 Contingent Consideration 47 per share1 47 CHF#.#bn [002] 47 Underlying pretax 47 Reclassifications 47 EBITDAX 47 FIFO EBITDA 47 distributable cash flow 47 prorations 47 NPAT 47 Intangible amortization 47 Tax Expense 47 Depreciation Amortization Taxes 47 acquisitions dispositions 47 Fineco Vita 47 Distributable Income 47 thequarter 47 2Q FY# [001] 47 TRY#.# [001] 47 - Adjusted [003] 47 amort 47 3Q FY# representing 47 EITF #-# [001] 47 SORL consolidated 47 j Represents 47 intercompany transactions 47 AOCL 47 SEK#.#bn [002] 47 asset write downs 47 Revenues 47 Acquired Intangible Assets 47 - -Belusko 47 Essentis 47 CFFO 47 - Non GAAP [004] 47 GAAP Diluted EPS 47 AWP litigation 47 REVENUES Revenues 47 mildly dilutive 47 Debt extinguishment 47 modified coinsurance 47 -David# 47 Q2 adj 47 THOMSONplus 47 Harland Clarke tradename 47 mandatorily redeemable preferred 47 -Laemmle Music 47 Other Specified Items 47 Normalized FFO 47 any dispositions monetizations 47 amortization #,#,# 47 EUR#.#M [003] 47 - Adjusted EBITDA [006] 47 underwriting discounts commissions 47 STECO acquisition 47 SFAS No.# 47 SEK #.#M #.# 47 -astrolabe 47 Headline PBIT 47 unaudited pro forma 47 TEUR -# 47 Recurring EBIT 47 meaningfully accretive 47 Fazenda Nova Mine 47 Jerneh Insurance Berhad 47 LILO transactions 47 IFRS IFRS 47 n#.# [001] 47 Adjusted Gross Margin 47 QSI segment certain 47 - - Nesignandsight newsletter 47 Q4 F# 47 Domestic Car Rental 47 financialperformance 47 unconsolidated investees 47 Fourgous transfers 47 NOI SS NOI 47 Q#/# [001] 47 - Operating [030] 47 deferred 47 -dnj.com 47 #.#/Mcfe 47 comparedto 47 - Loss [020] 47 Amortisation 47 income allocable

Back to home page